期刊文献+

依托芬那酯凝胶结合足矫形器治疗拇外翻的临床观察 被引量:1

Etofenamate Gel and Foot Orthosis for Painful Hallux Valgus:A Randomized Controlled Clinical Trail
原文传递
导出
摘要 目的了解依托芬那酯凝胶对有疼痛症状的轻中度拇外翻畸形的治疗效果。方法对2010年3月-2011年7月门诊收治的轻中度拇外翻患者共65足,随机分成两组,治疗组采取托芬那酯凝胶局部应用和佩戴夜间支具,对照组佩戴夜间支具,局部应用安慰剂,治疗周期1个月。记录症状明显缓解时间,治疗前后对患者进行视觉模拟疼痛评分和美国骨科足踝分会跖趾及趾间关节评分,并测量拇外翻角和第一跖骨间角改变。结果全部患者完成治疗,疼痛缓解时间治疗组为(3.28±1.04)d,对照组(7.03±2.15)d,差异有统计学意义(P<0.05),佩戴足矫形器治疗1个月,拇外翻角和第一跖骨间角改变无统计学差异(P>0.05)。结论局部应用依托芬那酯凝胶结合足矫形器治疗轻中度拇外翻能快速缓解疼痛症状,改善活动能力,延缓畸形加重,依托芬那酯凝胶局部给药患者能良好耐受,可避免口服非甾体抗炎药(NSAIDs)带来的副作用。 Objective To evaluate the therapeutic effect of etofenamate gel for painful hallux valgus.Methods From March 2010 to July 2010,65 patients with mild or moderate painful hallux valgus were randomly divided into observation group treated by etofenamate gel and foot orthosis,and control group treated by foot orthosis and placebo for one month.Outcome measures included the pain relief time,visual analogue scale,AOFAS Hallux Metatarsophalangealinterphalangeal(HMI) scale,hallux valgus angle and intermetatarsal angle at the beginning and the end of the treatment.Results All patients completed the treatment.There was no significant difference between the observation group [(3.28 ± 1.04) days] and the control group [(7.03 ± 2.15) days] in terms of the pain relief time(P < 0.05).There was no statistically significant difference in hallux valgus angle and intermetatarsal angle between the beginning and the end of the trail by foot orthosis treatment(P > 0.05).Conclusions Local application of etofenamate gel combined with foot orthosis treatment for mild to moderate hallux valgus can quickly relieve pain,improve mobility,and delay deformity.Localized drug delivery of etofenamate gel can be well tolerated by patients,and can avoid the side effects of oral NSAIDs.
出处 《华西医学》 CAS 2013年第3期365-368,共4页 West China Medical Journal
关键词 拇外翻 托芬那酯凝胶 足矫形器 Hallux valgus Etofenamate gel Foot orthosis
  • 相关文献

参考文献15

  • 1Wulker N, Mittag F. The treatment of hallux valgus[J]. Dtseh Arztebl Int,, 2012, 109(49): 857-868.
  • 2Bussewitz BW, Levar T, Hyer CF. Modem techniques in hallux abducto valgussurgery[J]. Clin Podiatr Med Surg, 2011, 28(2): 287-303.
  • 3Klemola T. Hallux valgus-several ways to treat[J]. Duodecim, 2011, 127(16): 1709-1718.
  • 4孙捷文,陈丽平.非甾体抗炎药的不良反应与合理使用[J].中国现代药物应用,2009,3(13):99-99. 被引量:6
  • 5Mann RA, Coughlin MJ. Surgery of the foot and Ankle[M]. 7th ed. St. Louis, MO: Mosby, 1999: 150-175.
  • 6Hahn MP, Gerhardt N, Thordarson DB. Medial capsular interpositionalarthroplasty for severe hallux rigidus[J]. Foot Ankle Int, 2009, 30(6): 494-499.
  • 7Nix SE, Vicenzino BT, Collins NJ, et al. Characteristics of foot structure and footwear associated with hallux valgus: a systematic review[J]. Osteoarthritis Cartilage, 2012, 10(20): 1059-1074.
  • 8Lee KM, Ahn S, Chung CY, et al. Reliability and relationship of radiographic measurements in Hallux Valgus[J]. Clin Orthop Relat Res, 2012, 9(470): 2613-2621.
  • 9石凯,刘志刚.“跖袖”的解剖学特点及临床意义[J].中国临床解剖学杂志,2007,25(3):266-268. 被引量:8
  • 10Dereymaeker G, Mulier T, Girisch P. The first metatarsophalangeal jointmeniscus and its relation to hallux valgus deformity - an anatomical and clinical study[J]. Foot Ankle Surg, 2011, 17(4): 270-273.

二级参考文献9

  • 1汤荣光,Wall.,WA.拇外翻患者前足足底压力分布的研究[J].中华外科杂志,1993,31(11):689-691. 被引量:7
  • 2陈立峰.对乙酰氨基酚的不良反应[J].海峡药学,2005,17(4):176-178. 被引量:23
  • 3Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and up- pergastrointestinal safety of celecoxib for treatment of osteoarthritisand rheumatoid arthritis: systematic review of randomised controlled trials. BMJ, 2002, 325 (7365) : 619.
  • 4Whelotal A. Renal and related cardiovascular effect of conventional and COX-2 specific NSAIDs and non-NSAIDs analgesics. Am J Ther, 2007:63-74.
  • 5MATSUMOTO K, NAMBU K, MORINO N, et al. Disposition and metabolism of [ ^14 C ] etofenamate in rats [ J ]. Yakuri to Chiryo, 1982,10 (8) :4409 -4421.
  • 6李大魁.解热镇痛抗炎及抗痛风药[M]//李大魁.现代临床药物学.第2版.北京:化学工业出版社,2003:248.
  • 7KLUG H. Experience with a locally applicable antirheumatic[ J]. Arzneimittelforsch, 1977, 27 ( 6 B ) : 1350 - 1354.
  • 8CHEREVATOV BG,SHELEST AN ,VOLNENKO NB, et al. Topical use of rhenmon-gel in the combined treatment of patients with rheumatoid arthritis[ J]. Ter Arkh, 1987, 59(12) : 100 - 102.
  • 9马昕,顾湘杰,黄煌渊,陈劲松,桂鉴超,夏新雷.足横弓三维形态的生物力学意义[J].中华骨科杂志,1998,18(9):528-531. 被引量:32

共引文献27

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部